Novo warns sales to tumble on tougher competition in US [Yahoo! Finance]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Yahoo! Finance
Sales at constant exchange rates will probably fall by 5% to 13%, the Danish drugmaker said in an early release of its outlook. Analysts expected a decline of 1.4%. Full results were scheduled to be published Wednesday. The company's American depositary receipts tumbled about 12% after a trading halt. The Copenhagen-listed shares had risen about 13% so far this year through Tuesday's close. The Danish drugmaker's annual sales last fell in 2017 amid a price war over insulin in the US. Novo is trying to fend off competition on multiple fronts, with rival Eli Lilly & Co.'s shot Zepbound taking leadership in the US market and generic copies of Ozempic likely to emerge in international markets later this year. Analysts had anticipated a conservative forecast and a decline in sales, but the magnitude of the potential drop is larger than had been predicted. Novo said that while the global GLP-1 market is expected to expand this year, with increased patient reach and higher volumes, lo
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Eli Lilly and Company (LLY) Q4 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Eli Lilly Stock Soars While Novo Nordisk Sinks—Why the Weight-Loss Leaders Are Headed in Opposite Directions [Yahoo! Finance]Yahoo! Finance
- Eil Lilly shares jump on strong GLP-1 sales, as Novo Nordisk tumbles [Yahoo! Finance]Yahoo! Finance
- Eli Lilly's GLP-1 growth is only getting started as Novo Nordisk braces for a decline in 2026 [CNBC]CNBC
- We're raising our price target on Eli Lilly as the GLP-1 leader delivers a huge beat [CNBC]CNBC
LLY
Earnings
- 2/4/26 - Beat
LLY
Sec Filings
- 2/4/26 - Form 8-K
- 2/3/26 - Form 4
- 2/3/26 - Form 4
- LLY's page on the SEC website